Cilostazol for Secondary Prevention of Stroke and Cognitive Decline: Systematic Review and Meta-Analysis

BACKGROUND AND PURPOSE: Cilostazol, a phosphodiesterase 3’ inhibitor, is used in Asia-Pacific countries for stroke prevention, but rarely used elsewhere. In addition to weak antiplatelet effects, it stabilizes endothelium, aids myelin repair and astrocyte-neuron energy transfer in laboratory models,...

詳細記述

保存先:
書誌詳細
出版年:Stroke
主要な著者: McHutchison, Caroline, Blair, Gordon W., Appleton, Jason P., Chappell, Francesca M., Doubal, Fergus, Bath, Philip M., Wardlaw, Joanna M.
フォーマット: Artigo
言語:Inglês
出版事項: Lippincott Williams & Wilkins 2020
主題:
Original Contributions
オンライン･アクセス:https://ncbi.nlm.nih.gov/pmc/articles/PMC7382534/
https://ncbi.nlm.nih.gov/pubmed/32646330
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1161/STROKEAHA.120.029454
タグ: タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!

類似資料